ACE inhibitor-based treatment and antihypertensive effects in patients with type 2 diabetes

Panminerva Medica

Volumn 50, Issue 3, 2008, Pages 207-216

  Jarmuzewska, E A ^a   Rocchi, R ^a   Guidoni, A ^a   Mangonp, A A ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Angiotensin converting enzyme inhibitors; Diabetes mellitus; Hyperglycemia; Hyperinsulinism; Hypertension; Insulin resistance; Type 2

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; TIME; TREATMENT OUTCOME;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 57349144457     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Fuller JH. Epidemiology of hypertension associated with diabetes mellitus. Hypertension 1985;7:113-7.
2. Ferrannini E, Buzzigoli G, Bonadonna R. Insulin resistance in essential hypertension. N Engl J Med 1987;317:350-7.
3. Modan M, Halkin H, Fuchs Z, Lusky A, Chetrit A, Segal P et al. Hyperinsulinemia - a link between glucose intolerance, obesity, hypertension, dyslipopoteinemia, elevated serum uric acid and internal cation imbalance. Diabete Metab 1987;13:375-80.
4. De Fronzo RA. The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia 1981;21:165-71.
5. Sowers JR, Levy J, Zemel MB. Hypertension and diabetes. Med Clin North Am 1988;72:1399-414.
6. Weidmann P, Beretta-Piccoli C, Trost BN. Pressor factors and responsiveness in hypertension accompanying diabetes mellitus. Hypertension 1985;7:1133-1142.
7. Beretta-Piccoli C, Weidmann P. Body sodium blood volume in nonazotemic diabetes mellitus. Miner Electrolyte Metab 1982;7:36-7.
8. Bröchner-Mortensen J. Glomerular filtration rate and extracellular fluid volume during normoglycemia and moderate hyperglycemia in diabetics. Scand J Clin Lab Invest 1973;32:311-6.
9. Anderson S, Brenner BM. Influence of antihypertensive therapy on development and progression of diabetic glomerulopathy. Diabetes Care 1988;11:846-9.
10. Sowers JR, Zemel MB. Clinical implications of hypertension in the diabetic patients. Am J Hypertens 1990;3:415-24.
11. Sowers JR. Relationship between hypertension and subtle and overt abnormalities of carbohydrate metabolism. J Am Soc Nephrol 1990;1:S39-S47.
12. Borle AB. Control, modulation, and regulation of cell calcium. Rev Physiol Biochem Pharmacol 1981;90:113-53.
13. Levy J, Zemel MB, Sowers JR. Role of cellular calcium metabolism in abnormal glucose metabolism and diabetic hypertension. Am J Med 1989;87:7S-16S.
14. Wong EC, Sacks DB, Laurino JP, McDonald JM. Characteristics of calmodulin phosphorylation by the insulin receptor kinase. Endocrinology 1988;123:1830-6.
15. Graves CB, Gale RD, Laurino JP, McDonald JM. The insulin receptor and calmodulin. Calmodulin enhances insulin-mediated receptor kinase activity and insulin stimulate phosphorylation of calmodulin. J Biol Chem 1986;261:10429-38.
16. Lytton J, Lin JC, Guidotti G. Identification of two molecular forms of (Na+, K+) ATPase in rat adipocytes. Relation to insulin stimulation of the enzyme. J Biol Chem 1985;260:1177-84.
17. Matlib MA, Schwartz A, Yamori Y. A Na+-Ca2+ exchange in isolated sarcolemmal membranes of mesenteric arteries from WKY and SHR rats. Am J Physiol 1985;249:C166-C172.
18. Schaefer W, Priessen J, Mannhold R, Gries AF. Ca2+-Mg2+-ATPase activity of human red blood cells in healthy and diabetic volunteers. Klin Wochenschr 1987;65:17-21.
19. Zemel MB, Bedford BA, Zemel PC, Marwah O, Sowers JR. Altered cation transport in non-insulin-dependent diabetic hypertension: effects of dietary calcium. J Hypertens 1988;6:S228-S230.
20. Johnson BA, Sowers JR, Zemel PC, Luft PC, Zemel MB. Increased sodium-lithium countertransport in black non-insuhn-dependent diabetic hypertensives. Am J Hypertens 1990;3:563-5.
21. Moore RD, Fidelman ML, Seeholzer SH. Correlation between insulin action upon glycolysis and change in intracellular PH. Biochem Biophys Res Commun 1979;91:905-10.
22. Moore RD. Stimulation of Na:H exchange by insulin. Biophys J 198;33:203-10.
23. Canessa M, Morgan K, Goldszer R, Moore TJ, Spalvins A. Kinetic abnormalities o the red blood cell sodium-proton exchange in hypertensive patients. Hypertension 1991;17:340-8.
24. Aviv A, Livne A. The N+/H+ antiport, cytosolic free Ca2+, and essential hypertension: a hypothesis. Am J Hypertens 1988;1:410-3.
25. Erne P, Hermsmeyer K. Intracellular vascular muscle Ca2+ modulation in genetic hypertension. Hypertension 1989;14:145-51.
26. Aimèr LA, Pandolfi M. Fibrinolysis and diabetic retinopathy. Diabetes 1976;25:807-10.
27. Juhan-Vague I, Alessi MC, Vague P. Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and afherotrombosis. Diabetologia 1991;34:457-62.
28. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979;241:2035-8.
29. Kannel WB, D'Agostino RB, Wilson PW, Belanger AJ. Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. Am Heart J 1990;120:672-6.
30. Harrison HE, Reece AH, Johnson M. Decreased vascular prostacyclin in experimental diabetes. Life Sci 1978;23:351-5.
31. Colwell JA, Winocour PD, Lopes-Virella M, Halushka PV. New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. Am J Med 1983;75:67-80.
32. Wang SL, Head J, Stevens L, Fuller JH. Excess mortality and its relation to hypertension and proteinuria in diabetic patients. The world health organization multinational study of vascular disease in diabetes. Diabetes Care 1996;19:305-12.
33. Bild D, Teutsch SM. The control of hypertension in persons with diabetes: a public health approach. Public Health Rep 1987;102:522-9.
34. Christlieb AR, Warrant JH, Krdlewski AS, Busick EJ, Ganda OP, Asmal AC et al. Hypertension: the major risk factor in juvenile-onset insulin-dependent diabetics. Diabetes 1981;30:90-6.
35. Oakley WG, Pyke DA, Tattersall RB, Watkins PJ. Long-term diabetes: A clinical study of 92 patients after 40 years. Q J Med 1974;43:145-56.
36. Borch-Johnsen K, Nissen H, Sailing N, Henriksen E, Kreiner S, Deckert T et al. The natural history of insulin-dependent diabetes in Denmark: 2. Long-term survival - who and why. Diab Med 1987;4:211-6.
37. Guidelines Sub-Committee. 1993 Guidelines for the management of mild hypertension: memorandum from a WHO/International Society of Hypertension. J Hypertension 1993;11:905-18.
38. 2003 European Society of Hypertension - European Society of Cardiology Guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53.
39. Falholt K, Cutfield R, Alejandro R, Heding L, Mintz D. The effects of hyperinsulinemia on arterial wall and peripheral muscle metabolism in dogs. Metabolism 1985;34:1146-9.
40. Banskota NK, Taub R, Zellner K, King GL. Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of the prooncogen c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells. Mol Endocrinol 1989;3:1183-90.
41. Modam M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M et al. Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest 1985;75:809-17.
42. Flack JM, Sowers JR. Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia. Am J Med 1991;91:11S-21S.
43. Haffner SM, Fong D, Hazuda HP, Pugh JA, Patterson JK. Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics. Metabolism 1988;37:338-45.
44. Lucas CP. Estigarribia JA, Darga LL, Reaven GM. Insulin and blood pressure in obesity. Hypertension 1985;7:702-6.
45. Manicardi V, Camellini L, Bellodi G, Coscelli C, Ferrannini E. Evidence for an association of high blood pressare and hyperinsulinemia in obese man. J Clin Endocrinol Metab 1986, 62:1302-4.
46. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989;149:1514-20.
47. Dall'Aglio E, Strata A, Reaven G. Abnormal lipid metabolism in treated hypertensive patients with non-insulin-dependent diabetes mellitus. Am J Med 1988;84:899-903.
48. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: The Framingham study. Circulation 1979;59:8-13.
49. Fuller JH. Shipley MJ, Rose G, Jarrett RJ, Keen H. Coronary-heartdisease risk and impaired glucose tolerance. The Whitehall study. Lancet 1980;1:1373-6.
50. Pan WH, Cedres LB, Liu K, Dyer A, Schoenberger JA, Shekelle RB et al. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 1986;123:504-16.
51. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998;317:703-13.
52. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53.